Let's hear it for .81 cents a share!!! Go team!!Love those stock options!

anonymous

Guest
Stock slid 12% today to .81 cents. This is really alarming. Before our eyes the stock is worthless in value. Management is hunkered down waiting for DS's lifeline of 300 million which only will buy some time. What is everyone doing in the field??
 




Stock slid 12% today to .81 cents. This is really alarming. Before our eyes the stock is worthless in value. Management is hunkered down waiting for DS's lifeline of 300 million which only will buy some time. What is everyone doing in the field??

What is everyone doing in the field ???

What is ANYONE doing in Management ???
 








Great to see the tape turn today, clearly we’re in a rough market, and the tensions in the Middle East have really dampened near term equity prices. The thesis remains the same, long and strong!
 




Another dipshit comment from the bleachers in Ann Arbor. Always an excuse.. covid, middle east tensions, Biden Economics. We haven't done anything right since launch. We're totally screwed as we try to kick start this penny stock..we're one fucked up company.
 












.84 cents a share. HILARIOUS!! where's all the chest trumpets bragging about The Scientific Hiring Process and when the stock was in the $70.00 range. What a dreadful performance since launch. You can't make this stuff up.
 




And just like that another Esperion paid finance article about how great things are going. This usually happens after a hard downfall of the stock. Since the stock has been under a $1.00 a share for over a month it can't climb out of the outhouse. This is like watching a train crash in slow motion.
 












Tough tape today and as investors continue to gravitate between equities and fixed-income, clearly the latter is gaining more attention with a 10 year now pushing five. So many of the high flying biotechs have really been hammered and ESPR is not immune from this price action Having said that, the comps are low, and with the coming earnings report, there could be a real catalyst for upside before EOY. It’s not too early to start thinking about a Santa Claus rally for the stock.
 




Tough tape today and as investors continue to gravitate between equities and fixed-income, clearly the latter is gaining more attention with a 10 year now pushing five. So many of the high flying biotechs have really been hammered and ESPR is not immune from this price action Having said that, the comps are low, and with the coming earnings report, there could be a real catalyst for upside before EOY. It’s not too early to start thinking about a Santa Claus rally for the stock.


Take another hit of the pipe Ann Arbor. Esperion isn't a high flying biotech! This is a tricycle competing in a NASCAR race. It'll be a Grinch Christmas for Esperion